Background: Pretreatment serum squamous cell carcinoma antigen (SCCA) is a prognostic biomarker in women with cervical cancer. SCCA has not been evaluated as an early indicator of response to chemoradiation therapy (CRT). The molecular role of the two SCCA isoforms, SCCA1 (SERPINB3) and SCCA2 (SERPINB4), in cervical cancer is unknown. We hypothesised that changes in serum SCCA during definitive CRT predicts treatment response, and that SCCA1 mediates radiation resistance.
Methods: Patients treated with definitive CRT for cervical squamous carcinoma with serum SCCA measured were included. SCCA immunohistochemistry was performed on tumour biopsies. Post-treatment FDG-PET/CT, recurrence, and overall survival were recorded. Radiation response of cervical tumour cell lines after SCCA1 expression or CRISPR/Cas9 knockout was evaluated by clonogenic survival assay.
Results: Persistently elevated serum SCCA during definitive CRT was an independent predictor of positive post-therapy FDG-PET/CT (P=0.043), recurrence (P=0.0046) and death (P=0.015). An SCCA1-expressing vector increased radioresistance, while SCCA knock out increased radiosensitivity of cervical tumour cell lines in vitro.
Conclusions: Early response assessment with serum SCCA is a powerful prognostic tool. These findings suggest that escalation of therapy in patients with elevated or sustained serum SCCA and molecular targeting of SCCA1 should be considered.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765231 | PMC |
| http://dx.doi.org/10.1038/bjc.2017.390 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Detection of Protein Markers From Blood Samples of Cervical Cancer Patients.
Cureus
October 2024
Microbiology, University of Dhaka, Dhaka, BGD.
Article Synopsis
- The study investigates the role of serum proteins as biomarkers for early detection of HPV-related cervical cancer, focusing on proteins like CEA, SCCA, HMGB1, and CYFRA 21-1.
- Analysis of blood samples from 36 cervical cancer patients revealed that CEA was the most frequently detected protein, highlighting variations based on different HPV types.
- The findings suggest that CEA could serve as a reliable biomarker for cervical cancer, especially in cases linked to HPV-16, which showed the highest response rates among the tested proteins.
Background: This study aimed to establish reference intervals for two biomarkers actively utilized in routine annual medical check-ups in China: squamous cell carcinoma antigen (SCCA) and cytokeratin 19 fragment (CYRFA 21-1), and to understand the influence of age, gender, and benign nodule(s) on their levels.
Methods: This prospective multicenter cross-sectional study continuously enrolled apparently healthy adults attending annual medical check-ups at three sites in 2019. Serum SCCA and CYFRA 21-1 levels were measured using electrochemiluminescence immunoassays.
Combining serum CDK1 with tumor markers for the diagnosis of small cell lung cancer.
Clin Transl Oncol
October 2024
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Article Synopsis
- The study investigates the role of cell cycle-dependent kinase 1 (CDK1) as a diagnostic tool for small cell lung cancer (SCLC) by comparing serum levels of CDK1 with other markers in different patient groups.
- Results show that CDK1 levels, along with other markers like ProGRP and NSE, are significantly higher in SCLC patients and correlate with cancer progression indicating its potential clinical value.
- The combination of CDK1, ProGRP, and NSE provides the most accurate diagnosis for SCLC, outperforming individual markers and demonstrating high sensitivity and specificity.
Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer.
Front Oncol
July 2024
Univ Rouen Normandie, Normandie Univ, Inserm U1245, Rouen, France.
Background: Cervical cancers are mainly caused by an oncogenic HPV. For locally advanced stages, the standard treatment is radio-chemotherapy (RTCT) followed by brachytherapy. Nevertheless, the prognosis remains highly heterogeneous between patients.
View Article and Find Full Text PDFAutocrine and paracrine effects of MDK promote lymph node metastasis of cervical squamous cell carcinoma.
iScience
July 2024
Department of Gynecology, Obstetrics & Gynecology Hospital, Fudan University, Shanghai 200011, China.
Lymph node metastasis (LNM) is the main metastatic pathway of cervical cancer, which is closely related to 5-year survival rate of cervical squamous cell carcinoma (CSCC), yet the underlying mechanism remains unconfirmed. In this study, we show that midkine (MDK) was highly expressed in CSCC and overexpression of MDK was associated with CSCC LNM. Functional investigations demonstrated that MDK promoted LNM by enhancing proliferation, migration and invasion capacity of cervical cancer cells, facilitating lymphangiogenesis and down-regulating the expression of tight junction proteins of human lymphatic endothelial cells (HLECs).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!